OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potent neutralization by monoclonal human IgM against SARS‐CoV‐2 is impaired by class switch
Ilaria Callegari, Mika Schneider, Giuliano Berloffa, et al.
EMBO Reports (2022) Vol. 23, Iss. 7
Open Access | Times Cited: 13
Ilaria Callegari, Mika Schneider, Giuliano Berloffa, et al.
EMBO Reports (2022) Vol. 23, Iss. 7
Open Access | Times Cited: 13
Showing 13 citing articles:
IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2
Malika Hale, Jason Netland, Yu Chen, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 9
Open Access | Times Cited: 36
Malika Hale, Jason Netland, Yu Chen, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 9
Open Access | Times Cited: 36
Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities
Natalie Rose, Sebastian Holdermann, Ilaria Callegari, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 5, pp. 1005-1025
Open Access | Times Cited: 27
Natalie Rose, Sebastian Holdermann, Ilaria Callegari, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 5, pp. 1005-1025
Open Access | Times Cited: 27
Defining and Studying B Cell Receptor and TCR Interactions
C. Garrett Rappazzo, Monica L. Fernández‐Quintero, Andreas Mayer, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 3, pp. 311-322
Closed Access | Times Cited: 12
C. Garrett Rappazzo, Monica L. Fernández‐Quintero, Andreas Mayer, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 3, pp. 311-322
Closed Access | Times Cited: 12
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 4
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 4
Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues
Somanath Kallolimath, Roman Palt, Esther Föderl-Höbenreich, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Somanath Kallolimath, Roman Palt, Esther Föderl-Höbenreich, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Status and Developing Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19
Zuning Ren, Chenguang Shen, Jie Peng
Viruses (2023) Vol. 15, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 5
Zuning Ren, Chenguang Shen, Jie Peng
Viruses (2023) Vol. 15, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 5
Designing Multivalent and Multispecific Biologics
Jennifer J. Kang, Ayako Ohoka, Casim A. Sarkar
Annual Review of Chemical and Biomolecular Engineering (2023) Vol. 15, Iss. 1, pp. 293-314
Closed Access | Times Cited: 3
Jennifer J. Kang, Ayako Ohoka, Casim A. Sarkar
Annual Review of Chemical and Biomolecular Engineering (2023) Vol. 15, Iss. 1, pp. 293-314
Closed Access | Times Cited: 3
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection
Michael Schoefbaenker, Theresa Günther, Eva U. Lorentzen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012624-e1012624
Open Access
Michael Schoefbaenker, Theresa Günther, Eva U. Lorentzen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012624-e1012624
Open Access
Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein
Kentarou Waki, Hideki Tani, Yumiko Saga, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Kentarou Waki, Hideki Tani, Yumiko Saga, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein
Kentarou Waki, Hideki Tani, Yumiko Saga, et al.
(2023)
Open Access
Kentarou Waki, Hideki Tani, Yumiko Saga, et al.
(2023)
Open Access
Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein
Kentarou Waki, Hideki Tani, Yumiko Saga, et al.
(2023)
Open Access
Kentarou Waki, Hideki Tani, Yumiko Saga, et al.
(2023)
Open Access
Glyco-engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues
Somanath Kallolimath, Roman Palt, Esther Föderl-Höbenreich, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Somanath Kallolimath, Roman Palt, Esther Föderl-Höbenreich, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
